Cited by 28

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

RECAM: A New and Improved, Computerized Causality Assessment Tool for DILI Diagnosis

Hayashi, Paul H., Lucena, M. Isabel, Fontana, Robert J.·2022·American Journal of Gastroenterology

Abstract

Hayashi, Paul H. MD, MPH, FAASLD; Lucena, M. Isabel MD, PhD; Fontana, Robert J. MD, FAASLD Author Information

Overview

Integrity signals

Registry

Crossref · 10.14309/ajg.0000000000001836

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In 194 DILI cases from the Spanish and DILIN registries, the area under the operator curves for identifying at least a probable causality category was the same for RUCAM and RECAM.

    “Hayashi et al. 49 compared RECAM with RUCAM for correlation with expert opinion in 194 DILI cases from the Spanish and the DILIN registries. The area under the operator curves (AUC) for identifying at least a probable causality category was the same for RUCAM and RECAM”
  • RECAM showed better overall agreement with expert opinion than RUCAM (.62 vs .56 weighted kappa, p = .14) and had greater sensitivity for extreme causality results.

    “although RECAM showed better overall agreement with expert opinion (.62 vs. .56 weighted kappa, p = .14), and had greater sensitivity for extreme causality results.”
  • RECAM requires external validation from regions other than US and Spain because it was developed based on case data from DILIN and the Spanish DILI Registry.

    “However, this method requires external validation from regions other than US and Spain since it was developed based on case data from Drug-Induced Liver Injury Network (DILIN) and the Spanish DILI Registry [61].”

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 9

  1. Danan, 1993, Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries, J Clin Epidemiol, 46, 1323, 10.1016/0895-4356(93)90101-6 · DOI · Paper page
  2. Benichou, 1993, Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge, J Clin Epidemiol, 46, 1331, 10.1016/0895-4356(93)90102-7 · DOI · Paper page
  3. Garcia-Cortes, 2011, Causality assessment methods in drug induced liver injury: Strengths and weaknesses, J Hepatol, 55, 683, 10.1016/j.jhep.2011.02.007 · DOI · Paper page
  4. Hayashi, 2009, Causality assessment in drug-induced liver injury, Semin Liver Dis, 29, 348, 10.1055/s-0029-1240003 · DOI
  5. Rockey, 2010, Causality assessment in drug-induced liver injury using a structured expert opinion process: Comparison to the roussel-Uclaf causality assessment method, Hepatology, 51, 2117, 10.1002/hep.23577 · DOI · Paper page
  6. Fontana, 2009, Drug-induced liver injury Network (DILIN) prospective study: Rationale, design and conduct, Drug Saf, 32, 55, 10.2165/00002018-200932010-00005 · DOI · Paper page
  7. Stephens, 2021, Comprehensive analysis and insights gained from long-term experience of the Spanish DILI registry, J Hepatol, 75, 86, 10.1016/j.jhep.2021.01.029 · DOI · Paper page
  8. Barritt, 2010, Detective work in drug-induced liver injury: Sometimes it is all about interviewing the right witness, Clin Gastroenterol Hepatol, 8, 635, 10.1016/j.cgh.2010.03.020 · DOI
  9. Medina-Caliz, 2018, Herbal and dietary supplement-induced liver injuries in the Spanish DILI registry, Clin Gastroenterol Hepatol, 16, 1495, 10.1016/j.cgh.2017.12.051 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Hayashi, P. H., Lucena, M. I., & Fontana, R. J.
Affiliations
  • Division of Hepatology and Nutrition, Food and Drug Administration, Silver Spring, Maryland, USA;
  • Servicio de Farmacologia Clinica, Instituto de Investigacion Biomedica de Malaga-IBIMA, Hospital Universitario Virgen de la Victoria, Universidad de Malaga, Malaga Spain. CIBERehd, Madrid, Spain;
  • Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.
Venue
American Journal of Gastroenterology
Published
2022-05-25
Volume
117
Issue
9
Pages
1387-1389
ISSN
  • 0002-9270
  • 1572-0241
Cited by
28
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review